PHARMCONSULT AS

1369 STABEKK

Finances

Return on Equity

32,09 %

Current Ratio

2,6

Debt-to-Equity Ratio

0,34

Key figures (NOK)	2022	2021	2020	2019
Revenue	4 154 000	4 567 000	3 004 000	4 653 000
Net Income	1 598 000	2 054 000	1 288 000	2 246 000
Total Assets	8 031 000	6 719 000	7 223 000	6 562 000
Total Equity	4 980 000	3 382 000	4 328 000	3 040 000

Income (NOK)	2022	2021	2020	2019
Revenue	4 154 000	4 567 000	3 004 000	4 653 000
Expenditure	2 084 000	1 931 000	1 421 000	1 733 000
Operating Profit	2 070 000	2 636 000	1 583 000	2 920 000
Financial Income	44 000	44 000	114 000	13 000
Financial Costs	65 000	54 000	67 000	56 000
Financial Balance	−21 000	−10 000	47 000	−43 000
Earnings Before Tax	2 048 000	2 626 000	1 630 000	2 877 000
Tax	451 000	572 000	343 000	631 000
Net Income	1 598 000	2 054 000	1 288 000	2 246 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	4 486 000	4 234 000	4 254 000	3 848 000
Total Current Assets	3 545 000	2 485 000	2 969 000	2 714 000
Total Assets	8 031 000	6 719 000	7 223 000	6 562 000
Total Retained Equity	4 880 000	3 282 000	4 228 000	0
Total Equity	4 980 000	3 382 000	4 328 000	3 040 000
Total Long-Term Debt	1 689 000	1 945 000	2 201 000	2 457 000
Total Current Debt	1 362 000	1 391 000	694 000	1 064 000
Total Equity and Debt	8 031 000	6 719 000	7 223 000	6 562 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	4 078 000	4 507 000	2 944 000	4 593 000
Other Income	76 000	60 000	60 000	60 000
Revenue	4 154 000	4 567 000	3 004 000	4 653 000
Cost of Goods Sold	700 000	512 000	530 000	829 000
Salary Costs	962 000	968 000	494 000	492 000
Depreciation	0	0	0	0
Impairment	0	0	0	0
Expenditure	2 084 000	1 931 000	1 421 000	1 733 000
Operating Profit	2 070 000	2 636 000	1 583 000	2 920 000
Financial Income	44 000	44 000	114 000	13 000
Financial Costs	65 000	54 000	67 000	56 000
Financial Balance	−21 000	−10 000	47 000	−43 000
Dividends	0	3 000 000	0	0
Net Income	1 598 000	2 054 000	1 288 000	2 246 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	0	0	0	0
Real Eastate	3 464 000	3 464 000	3 449 000	3 243 000
Machinery and Plant Facilities	0	0	0	0
Fixtures	0	0	0	0
Total Tangible Assets	3 464 000	3 464 000	3 449 000	3 243 000
Total Fiancial Fixed Assets	1 022 000	770 000	805 000	605 000
Total Fixed Assets	4 486 000	4 234 000	4 254 000	3 848 000
Stock	0	0	5 000	0
Total Investments	542 000	497 000	0	0
Cash, Bank	1 389 000	139 000	1 838 000	1 447 000
Total Current Assets	3 545 000	2 485 000	2 969 000	2 714 000
Total Assets	8 031 000	6 719 000	7 223 000	6 562 000
Total Equity	4 980 000	3 382 000	4 328 000	3 040 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	1 689 000	1 945 000	2 201 000	2 457 000
Creditors	94 000	119 000	62 000	0
Unpaid Taxes	314 000	445 000	240 000	297 000
Dividends	0	3 000 000	0	0
Other Current Debt	503 000	255 000	49 000	136 000
Total Current Debt	1 362 000	1 391 000	694 000	1 064 000
Total Equity and Debt	8 031 000	6 719 000	7 223 000	6 562 000

Financial indicators	2022	2021	2020	2019
Return on Equity	32,09 %	60,73 %	29,76 %	73,88 %
Debt-to-Equity Ratio	0,34	0,58	0,51	0,81
Operating Profit Margin	49,83 %	57,72 %	52,7 %	62,76 %
Current Ratio	2,6	1,79	4,28	2,55
Quick Ratio	2,6	1,79	4,31	2,55
Equity Ratio	0,62	0,5	0,6	0,46
Gross Profit Margin	83,15 %	88,79 %	82,36 %	82,18 %